콘텐츠로 건너뛰기
Merck
  • Biosynthesis of anti-HCV compounds using thermophilic microorganisms.

Biosynthesis of anti-HCV compounds using thermophilic microorganisms.

Bioorganic & medicinal chemistry letters (2012-09-11)
Cintia W Rivero, Eliana C De Benedetti, Jorge E Sambeth, Mario E Lozano, Jorge A Trelles
초록

This work describes the application of thermophilic microorganisms for obtaining 6-halogenated purine nucleosides. Biosynthesis of 6-chloropurine-2'-deoxyriboside and 6-chloropurine riboside was achieved by Geobacillus stearothermophilus CECT 43 with a conversion of 90% and 68%, respectively. Furthermore, the selected microorganism was satisfactorily stabilized by immobilization in an agarose matrix. This biocatalyst can be reused at least 70 times without significant loss of activity, obtaining 379mg/L of 6-chloropurine-2'-deoxyriboside. The obtained compounds can be used as antiviral agents.

MATERIALS
제품 번호
브랜드
제품 설명

Sigma-Aldrich
6-Chloropurine riboside, 99%